TET3
Basic information
Region (hg38): 2:73984910-74108177
Links
Phenotypes
GenCC
Source:
- Beck-Fahrner syndrome (Moderate), mode of inheritance: Semidominant
- Beck-Fahrner syndrome (Moderate), mode of inheritance: Semidominant
- Beck-Fahrner syndrome (Strong), mode of inheritance: AR
- Beck-Fahrner syndrome (Limited), mode of inheritance: AR
- Beck-Fahrner syndrome (Definitive), mode of inheritance: AD
- Beck-Fahrner syndrome (Strong), mode of inheritance: AR
- Beck-Fahrner syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Beck-Fahrner syndrome | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 31928709 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (247 variants)
- Beck-Fahrner_syndrome (102 variants)
- TET3-related_disorder (56 variants)
- Inborn_genetic_diseases (34 variants)
- TET3_deficiency (10 variants)
- not_specified (7 variants)
- Neurodevelopmental_disorder (3 variants)
- Schizophrenia (1 variants)
- Intellectual_disability (1 variants)
- See_cases (1 variants)
- Multiple_myeloma (1 variants)
- Neurodevelopmental-craniofacial_syndrome_with_variable_renal_and_cardiac_abnormalities (1 variants)
- Developmental_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TET3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001287491.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 51 | 63 | ||||
| missense | 17 | 245 | 22 | 287 | ||
| nonsense | 11 | 15 | ||||
| start loss | 0 | |||||
| frameshift | 15 | 24 | ||||
| splice donor/acceptor (+/-2bp) | 3 | |||||
| Total | 7 | 44 | 258 | 73 | 10 |
Highest pathogenic variant AF is 0.000019721754
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TET3 | protein_coding | protein_coding | ENST00000409262 | 9 | 105464 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 1.04e-8 | 124619 | 0 | 4 | 124623 | 0.0000160 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.88 | 732 | 986 | 0.742 | 0.0000607 | 10594 |
| Missense in Polyphen | 172 | 376.76 | 0.45653 | 4067 | ||
| Synonymous | -1.04 | 460 | 432 | 1.06 | 0.0000294 | 3541 |
| Loss of Function | 6.75 | 1 | 55.1 | 0.0181 | 0.00000271 | 636 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000556 | 0.0000556 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000270 | 0.0000266 |
| Middle Eastern | 0.0000556 | 0.0000556 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5- hydroxymethylcytosine (5hmC) and plays a key role in epigenetic chromatin reprogramming in the zygote following fertilization. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation (By similarity). Selectively binds to the promoter region of target genes and contributes to regulate the expression of numerous developmental genes (PubMed:23217707). In zygotes, DNA demethylation occurs selectively in the paternal pronucleus before the first cell division, while the adjacent maternal pronucleus and certain paternally-imprinted loci are protected from this process. Participates in DNA demethylation in the paternal pronucleus by mediating conversion of 5mC into 5hmC, 5fC and 5caC. Does not mediate DNA demethylation of maternal pronucleus because of the presence of DPPA3/PGC7 on maternal chromatin that prevents TET3- binding to chromatin (By similarity). In addition to its role in DNA demethylation, also involved in the recruitment of the O- GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT (PubMed:23353889). {ECO:0000250|UniProtKB:Q8BG87, ECO:0000269|PubMed:23217707, ECO:0000269|PubMed:23353889}.;
- Pathway
- MECP2 and Associated Rett Syndrome;TET1,2,3 and TDG demethylate DNA;Epigenetic regulation of gene expression;Gene expression (Transcription)
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.129
- rvis_EVS
- -1.51
- rvis_percentile_EVS
- 3.48
Haploinsufficiency Scores
- pHI
- 0.858
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.577
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0980
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tet3
- Phenotype
- reproductive system phenotype; cellular phenotype;
Gene ontology
- Biological process
- 5-methylcytosine catabolic process;protein O-linked glycosylation;DNA demethylation of male pronucleus;positive regulation of transcription by RNA polymerase II;oxidation-reduction process;oxidative demethylation;DNA demethylation;histone H3-K4 trimethylation
- Cellular component
- female pronucleus;male pronucleus;nucleus;chromosome;cytoplasm
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;iron ion binding;protein binding;methylcytosine dioxygenase activity